New coronavirus research shows that when infected with the coronaviruses coronavirosts, people who are infected can experience severe neurological symptoms and can be killed by breathing in COVID-19.
The new study, published in the journal Science Translational Medicine, looked at about 2,300 coronaviral infections in patients with a high-risk of getting the coronovirus.
The participants were mostly people with respiratory disease, including COPD, and had been infected with coronavurids in the past.
The study is not a randomized clinical trial.
The researchers said that the participants showed a marked increase in the amount of COVIDs they had in the lungs after the first two months of the study.
The average time between first and last COVID infection was two weeks.
The researchers said they expect the number of infections in the study will rise as more people get vaccinated.
They also noted that the study was small and didn’t examine other infections that might have occurred before and after the two months, like respiratory infections.
The study is also not a random trial.
Scientists can’t randomly select patients and randomly assign them to a specific study.
They have to take a sample of the virus and then look at it to see if the person has the virus.
The CDC has said that if there are any long-term health effects associated with the study, it will be made public.
The company that manufactured the vaccine has not responded to questions about whether it would be making a public announcement.